On the origins of clinical drug resistance Journal Article


Authors: O'Brien, J. P.; Cordon-Cardo, C.
Article Title: On the origins of clinical drug resistance
Abstract: Recent progress in understanding the clinical importance of certain laboratory models of drug resistance is cause for clinical oncologists to rethink some of the current concepts used in developing chemotherapy programs. The following discussion will reexamine a popular model of resistance development and highlight certain insights gained from clinical and laboratory studies of multidrug resistance. Such insights both challenge traditional concepts of cancer treatment and suggest new therapeutic approaches that would otherwise not have been apparent. © 1991 by W.B. Saunders Company.
Keywords: cancer chemotherapy; genetics; review; antineoplastic agents; antineoplastic agent; neoplasm; neoplasms; mouse; animal; metabolism; mice; biological model; models, biological; drug resistance; physiology; gene expression regulation; gene expression regulation, neoplastic; membrane glycoproteins; membrane protein; multidrug resistance; p-glycoprotein; glycoprotein p; human; male; female; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
Journal Title: Seminars in Cancer Biology
Volume: 2
Issue: 4
ISSN: 1044-579X
Publisher: Academic Press Inc., Elsevier Science  
Date Published: 1991-08-01
Start Page: 227
End Page: 233
Language: English
PUBMED: 1680494
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Citation Impact
MSK Authors
  1. James O'Brien
    28 O'Brien